[IPO] Celltrion Healthcare seeks largest-ever KOSDAQ listing

[THE INVESTOR] Celltrion Healthcare, the marketing affiliate of biopharma firm Celltrion, said on July 18 it has set the price for its initial public offering at 41,000 won (US$36.43), marking the largest listing on the nation’s secondary bourse KOSDAQ. The firm aims to raise about 1 trillion won through the listing on July 28 with plans to use it for diversifying its drug pipeline through acquisitions and expanding its sales network overseas. The exclusive distributor for Celltrion’s biosimilar

Leave a Reply

Your email address will not be published.

1 + 14 =